ESPEROMAX
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Oct 2023)
What this means for you
This application is over — abandoned 30 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90680240
- Mark type
- Stylized text
- Filed
- 29 Apr 2021
- Published for opposition
- 01 Feb 2022
- Abandoned
- 30 Oct 2023
- Attorney of record
- J. Matthew Buchanan
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of disease; Biological preparations, namely, proteins, for the treatment of disease; Biological preparations, namely, antibodies, for the treatment of disease; Biological preparations, namely, hormones, for the treatment of disease; Biological preparations, namely, preparations for use in the treatment of cancer, inflammation, and/or infectious disease
Owner
- Esperovax, Inc., Plymouth, MI, US
- Esperovax, Inc., Plymouth, MI, US
Prosecution history
- 30 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2023 — SOU EXTENSION 2 GRANTED
- 09 Mar 2023 — SOU EXTENSION 2 FILED
- 09 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 27 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2022 — SOU EXTENSION 1 GRANTED
- 23 Sept 2022 — SOU EXTENSION 1 FILED
- 23 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 29 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Feb 2022 — PUBLISHED FOR OPPOSITION
- 12 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER